Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, Brigitte Anliker, Silvia Arcangeli, Chiara Bonini, Biagio De Angelis, Rashmi Choudhary, David Espie, Anne Galy, Cam Holland, Zoltán Ivics, Chahrazade Kantari-Mimoun, Marie Jose Kersten, Ulrike KöhlSee the full list of authors
16 May 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, Paula Barbao, Chiara Bonini, Philippe Bousso, Christian J Buchholz, Monica Casucci, Biagio De Angelis, Emmanuel Donnadieu, David Espie, Beatrice Greco, Richard Groen, Johannes B Huppa, Chahrazade Kantari-MimounSee the full list of authors
16 May 2022
Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?Syrine Abdeljaoued, Sara Arfa, Marie Kroemer, Myriam Ben Khelil, Angélique Vienot, Bruno Heyd, Romain Loyon, Alexandre Doussot, Christophe Borg
25 April 2022
JAK inhibitors and COVID-19Gabriel Levy, Paola Guglielmelli, Peter Langmuir, Stefan N Constantinescu
22 April 2022
Immunogenicity assessment of bispecific antibody-based immunotherapy in oncologyYanchen Zhou, Hweixian L Penny, Mark A Kroenke, Bianca Bautista, Kelly Hainline, Lynette S Chea, Jane Parnes, Daniel T Mytych
20 April 2022
Tumor-associated macrophages in multiple myeloma: advances in biology and therapyJennifer Sun, Chaelee Park, Nicole Guenthner, Shannon Gurley, Luna Zhang, Berit Lubben, Ola Adebayo, Hannah Bash, Yixuan Chen, Mina Maksimos, Barbara Muz, Abdel Kareem Azab
15 April 2022
The use of oncolytic virotherapy in the neoadjuvant settingRaquela J Thomas, Eric Bartee
12 April 2022
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapyEugene Y Chiang, Ira Mellman
4 April 2022
To go or not to go? Biological logic gating engineered T cellsRebecca C Abbott, Hannah E Hughes-Parry, Misty R Jenkins
4 April 2022
Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapyYeonggyeong Park, Min Jeong Kim, Yoonhee Choi, Na Hyun Kim, Leeseul Kim, Seung Pyo Daniel Hong, Hyung-Gyo Cho, Emma Yu, Young Kwang Chae
28 March 2022
